Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.040
-0.010 (-0.95%)
Sep 4, 2026, 2:32 PM EDT - Market open
Tempest Therapeutics Employees
Tempest Therapeutics had 4 employees as of June 30, 2026. The number of employees decreased by 17 or -80.95% compared to the same quarter last year.
Employees
4
Change
-17
Growth
-80.95%
Revenue / Employee
n/a
Profits / Employee
-$10,118,000
Market Cap
16.62M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 4 | -17 | -80.95% |
| Mar 31, 2026 | 5 | -19 | -79.17% |
| Dec 31, 2025 | 4 | -20 | -83.33% |
| Sep 30, 2025 | 5 | -19 | -79.17% |
| Jun 30, 2025 | 21 | - | - |
| Dec 31, 2024 | 24 | 7 | 41.18% |
| Dec 31, 2023 | 17 | -2 | -10.53% |
| Dec 31, 2022 | 19 | 2 | 11.76% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| BioCardia | 21 |
| CalciMedica | 16 |
| BioVie | 13 |
| Psyence Biomedical | 12 |
| Quoin Pharmaceuticals | 6 |
| Adial Pharmaceuticals | 5 |
TPST News
- 13 days ago - Tempest Therapeutics files to sell 8.91M shares of common stock for holders - TheFly
- 14 days ago - Tempest Therapeutics Registration statement: Registration filing - Filings
- 17 days ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 21 days ago - Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 21 days ago - Tempest Therapeutics Earnings release: Q2 2026 - Filings
- 21 days ago - Tempest Therapeutics Quarterly report: Q2 2026 - Filings
- 5 weeks ago - Tempest Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T - GlobeNewsWire